The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: a systematic review and meta-analysis
出版年份 2019 全文链接
标题
The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: a systematic review and meta-analysis
作者
关键词
Lung cancer, EGFR, Brain metastasis, Prognosis, Meta analysis
出版物
BMC CANCER
Volume 19, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-02-13
DOI
10.1186/s12885-019-5331-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer
- (2018) Min Young Baek et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Correlation between EGFR mutation status and the incidence of brain metastases in patients with non-small cell lung cancer
- (2017) Lina Li et al. Journal of Thoracic Disease
- EGFR mutation status on brain metastases from non-small cell lung cancer
- (2016) Fred Hsu et al. LUNG CANCER
- Épidémiologie des lésions métastatiques cérébrales
- (2015) S. Taillibert et al. Cancer Radiotherapie
- Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?
- (2015) Tony J. C. Wang et al. NEURO-ONCOLOGY
- Exon 19 deletion of epidermal growth factor receptor is associated with prolonged survival in brain metastases from non-small-cell lung cancer
- (2015) Hongwei Li et al. TUMOR BIOLOGY
- EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?
- (2014) L.E.L. Hendriks et al. LUNG CANCER
- Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastases
- (2014) K. S. Mak et al. NEURO-ONCOLOGY
- Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival
- (2014) Karmen Stanic et al. Radiology and Oncology
- Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial
- (2013) Yi-Long Wu et al. LANCET ONCOLOGY
- Impact of epidermal growth factor receptor mutations on intracranial treatment response and survival after brain metastases in lung adenocarcinoma patients
- (2013) Shih-Hsin Hsiao et al. LUNG CANCER
- Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma
- (2013) T. Iuchi et al. LUNG CANCER
- EGFR mutation status and its impact on survival of Chinese non-small cell lung cancer patients with brain metastases
- (2013) Dongdong Luo et al. TUMOR BIOLOGY
- Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma
- (2013) HongQing Zhuang et al. Drug Design Development and Therapy
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers
- (2012) S. Dogan et al. CLINICAL CANCER RESEARCH
- The Impact of Initial Gefitinib or Erlotinib versus Chemotherapy on Central Nervous System Progression in Advanced Non-Small Cell Lung Cancer with EGFR Mutations
- (2012) S. Heon et al. CLINICAL CANCER RESEARCH
- EGFR mutations are associated with favorable intracranial response and progression-free survival following brain irradiation in non-small cell lung cancer patients with brain metastases
- (2012) Hsin-Lun Lee et al. Radiation Oncology
- EGFR Nuclear Translocation Modulates DNA Repair following Cisplatin and Ionizing Radiation Treatment
- (2011) G. Liccardi et al. CANCER RESEARCH
- Effectiveness of Tyrosine Kinase Inhibitors on "Uncommon" Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non-Small Cell Lung Cancer
- (2011) J.-Y. Wu et al. CLINICAL CANCER RESEARCH
- Autocrine VEGF Signaling Synergizes with EGFR in Tumor Cells to Promote Epithelial Cancer Development
- (2010) Beate M. Lichtenberger et al. CELL
- Lung Adenocarcinoma From East Asian Never-Smokers Is a Disease Largely Defined by Targetable Oncogenic Mutant Kinases
- (2010) Yihua Sun et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer
- (2010) A. F. Eichler et al. NEURO-ONCOLOGY
- Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis
- (2009) Oscar Arrieta et al. BMC CANCER
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epidermal Growth Factor Receptor Gene Amplification Is Acquired in Association with Tumor Progression of EGFR-Mutated Lung Cancer
- (2008) Y. Yatabe et al. CANCER RESEARCH
- Radiotherapy in Lung Adenocarcinoma with Brain Metastases: Effects of Activating Epidermal Growth Factor Receptor Mutations on Clinical Response
- (2008) C.-H. Gow et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More